Cybin Inc (CLXPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLXPF | BMY | AMGN | GILD | REGN |
| Company | Cybin Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 3.0500 | 70.32 | 243.78 | 82.37 | 749.20 |
| High | 3.2000 | 72.61 | 243.78 | 82.50 | 758.72 |
| Low | 2.8736 | 69.80 | 236.37 | 80.60 | 741.45 |
| Last | 3.0200 | 72.07 | 240.80 | 81.18 | 754.38 |
| Change | -0.0400 | +0.84 | -5.61 | -2.82 | -3.62 |
| % Change | -1.31% | +1.18% | -2.28% | -3.36% | -0.48% |
| Volume | 864,300 | 6,013,825 | 2,556,978 | 5,454,598 | 449,733 |
| 20-Day Average Volume | 1,094,590 | 8,186,401 | 2,345,962 | 6,319,972 | 632,058 |
| Previous Close | 3.0600 | 71.23 | 246.41 | 84.00 | 758.00 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.8482 | 72.41 | 261.82 | 84.61 | 728.37 |
| 20-Day Raw Stochastic | 71.64% | 44.04% | 8.03% | 6.37% | 91.03% |
| 20-Day Relative Strength | 62.45% | 44.92% | 26.96% | 40.18% | 56.74% |
| Weighted Alpha | +130.72 | +5.51 | +1.61 | +31.10 | +18.07 |
| Today's Opinion | N/A | 56% Sell | 8% Sell | 40% Buy | 64% Buy |
| Previous Opinion | N/A | 56% Sell | 8% Sell | 40% Buy | 64% Buy |
| Last Month's Opinion | N/A | 24% Sell | 40% Buy | 80% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.46% since 07/28/21 | -1.23% since 01/26/23 | -5.99% since 01/26/23 | -3.03% since 01/26/23 | +1.53% since 01/26/23 |
| Low | 2.7300 on 07/29/21 | 69.80 on 02/02/23 | 236.37 on 02/02/23 | 80.60 on 02/02/23 | 732.49 on 01/30/23 |
| High | 3.3800 on 08/02/21 | 73.45 on 01/27/23 | 255.50 on 01/27/23 | 84.65 on 02/01/23 | 762.09 on 02/01/23 |
| 1-Month | |||||
| %Chg | +42.45% since 07/02/21 | +0.19% since 12/30/22 | -8.76% since 12/30/22 | -5.54% since 12/30/22 | +4.46% since 12/30/22 |
| Low | 2.1105 on 07/08/21 | 69.80 on 02/02/23 | 236.37 on 02/02/23 | 80.60 on 02/02/23 | 668.00 on 01/09/23 |
| High | 3.3800 on 08/02/21 | 75.00 on 01/24/23 | 276.84 on 01/11/23 | 88.29 on 01/06/23 | 762.09 on 02/01/23 |
| 3-Month | |||||
| %Chg | +79.76% since 05/04/21 | -6.92% since 11/02/22 | -10.93% since 11/02/22 | +4.12% since 11/02/22 | +1.78% since 11/02/22 |
| Low | 1.3429 on 06/01/21 | 69.80 on 02/02/23 | 236.37 on 02/02/23 | 77.16 on 11/03/22 | 668.00 on 01/09/23 |
| High | 3.3800 on 08/02/21 | 81.43 on 12/01/22 | 296.67 on 11/08/22 | 89.74 on 12/13/22 | 779.00 on 12/08/22 |
| 6-Month | |||||
| %Chg | +76.61% since 02/04/21 | -1.62% since 08/02/22 | -1.76% since 08/02/22 | +36.19% since 08/02/22 | +31.08% since 08/02/22 |
| Low | 0.9500 on 03/30/21 | 65.95 on 08/30/22 | 223.30 on 09/22/22 | 60.62 on 08/05/22 | 572.22 on 09/06/22 |
| High | 3.3800 on 08/02/21 | 81.43 on 12/01/22 | 296.67 on 11/08/22 | 89.74 on 12/13/22 | 779.00 on 12/08/22 |
| Key Statistics | |||||
| Market Capitalization, $K | 453,224 | 151,446,384 | 131,479,200 | 105,356,496 | 82,547,712 |
| Shares Outstanding, K | 148,598 | 2,126,160 | 533,579 | 1,254,244 | 108,902 |
| Annual Sales | 650,000 | 46,385,000,000 | 25,979,000,000 | 27,305,000,000 | 16,071,700,000 |
| Annual Net Income | -24,420,000 | 6,994,000,000 | 5,893,000,000 | 6,225,000,000 | 8,075,300,000 |
| Last Quarter Sales | N/A | 11,218,000,000 | 6,652,000,000 | 7,042,000,000 | 2,936,200,000 |
| Last Quarter Net Income | N/A | 1,606,000,000 | 2,143,000,000 | 1,789,000,000 | 1,315,700,000 |
| 60-Month Beta | N/A | 0.43 | 0.64 | 0.39 | 0.25 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.99 on 10/25/22 | 4.09 on 01/31/23 | 1.90 on 10/27/22 | 11.14 on 11/03/22 |
| Latest Earnings Date | N/A | 02/02/23 | 01/31/23 | 02/02/23 | 02/03/23 |
| Most Recent Dividend | N/A | 0.570 on 01/05/23 | 1.940 on 11/16/22 | 0.730 on 12/14/22 | N/A |
| Next Ex-Dividends Date | N/A | 01/05/23 | 02/14/23 | 12/14/22 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 9.42 | 14.27 | 13.35 | 13.80 |
